Pharma Equity Group Balance Sheet Health
Financial Health criteria checks 5/6
Pharma Equity Group has a total shareholder equity of DKK25.5M and total debt of DKK7.4M, which brings its debt-to-equity ratio to 29.1%. Its total assets and total liabilities are DKK38.9M and DKK13.4M respectively.
Key information
29.12%
Debt to equity ratio
DKK 7.42m
Debt
| Interest coverage ratio | n/a |
| Cash | DKK 498.00k |
| Equity | DKK 25.47m |
| Total liabilities | DKK 13.43m |
| Total assets | DKK 38.90m |
Recent financial health updates
We Think Pharma Equity Group (CPH:PEG) Has A Fair Chunk Of Debt
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Here's Why Pharma Equity Group (CPH:PEG) Can Afford Some Debt
CPSE:PEG 1 Year Share Price vs Fair Value Explore Pharma Equity Group's Fair Values from the Community and select yours...We Think Pharma Equity Group (CPH:PEG) Has A Fair Chunk Of Debt
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Is Pharma Equity Group (CPH:PEG) A Risky Investment?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Would Pharma Equity Group (CPH:PEG) Be Better Off With Less Debt?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...Pharma Equity Group (CPH:PEG) Is Making Moderate Use Of Debt
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Recent updates
Financial Position Analysis
Short Term Liabilities: PEG's short term assets (DKK38.3M) exceed its short term liabilities (DKK8.8M).
Long Term Liabilities: PEG's short term assets (DKK38.3M) exceed its long term liabilities (DKK4.6M).
Debt to Equity History and Analysis
Debt Level: PEG's net debt to equity ratio (27.2%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if PEG's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: PEG has sufficient cash runway for 0 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: PEG is forecast to have sufficient cash runway for 0 months based on free cash flow estimates, but has since raised additional capital.
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/26 18:06 |
| End of Day Share Price | 2026/06/26 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Pharma Equity Group A/S is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.